Výsledky vyhledávání - "Kelvin H.-V. Tan"

Absence of Cochleotoxicity Measured by Standard and High-Frequency Pure Tone Audiometry in a Trial of Once- versus Three-Times-Daily Tobramycin in Cystic Fibrosis Patients

Autor: Alan J. Knox, David Stableforth, Pauline Hyman-Taylor, Kelvin H.-V. Tan, Sarah Lewis, Alan R. Smyth, Michael Mulheran

Publikováno v: Antimicrobial Agents and Chemotherapy. 50:2293-2299

We undertook assessment of hearing in patients with cystic fibrosis who were taking part in a large randomized controlled trial of once- versus three-times-daily tobramycin for pulmonary exacerbations of cystic fibrosis (the TOPIC study). All patient

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4866c597325c98fbc024e1f55fcf7721
https://doi.org/10.1128/aac.00995-05

Zobrazit plný text záznamu

Once versus three-times daily regimens of tobramycin treatment for pulmonary exacerbations of cystic fibrosis—the TOPIC study: a randomised controlled trial

Autor: Michael Mulheran, Pauline Hyman-Taylor, Alan J. Knox, Kelvin H.-V. Tan, Sarah Lewis, Alan R. Smyth, David Stableforth

Publikováno v: The Lancet. 365:573-578

Summary Background Intravenous tobramycin (three-times daily) is widely used for pulmonary exacerbations in patients with cystic fibrosis who have chronic Pseudomonas aeruginosa infection. We undertook a double-blind, randomised controlled trial to a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afe468780821f8ab47ab9a1b2204814f
https://doi.org/10.1016/s0140-6736(05)17906-9

Zobrazit plný text záznamu

Aminoglycoside Prescribing and Surveillance in Cystic Fibrosis

Autor: Michael Mulheran, Alan R. Smyth, Kelvin H.-V. Tan, Alan J. Knox

Publikováno v: American Journal of Respiratory and Critical Care Medicine. 167:819-823

lean mass, of which 70% is body water and the remainder muscle. After intravenous administration, aminoglycosides distribute rapThe potential of aminoglycoside antibiotics to cause ototoxic idly throughout the extracellular fluid compartment, with pe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d3a1a089f9506097ab220c2c6fd3b33
https://doi.org/10.1164/rccm.200109-012cc

Zobrazit plný text záznamu

Akademický článek

Once versus three-times daily regimens of tobramycin treatment for pulmonary exacerbations of cystic fibrosis -- the TOPIC study: a randomised controlled trial.

Autor: Smyth A (AUTHOR), Tan KH (AUTHOR), Hyman-Taylor P (AUTHOR), Mulheran M (AUTHOR), Lewis S (AUTHOR), Stableforth D (AUTHOR), Knox A (AUTHOR), TOPIC Study Group (CORPORATE AUTHOR)

Publikováno v: Lancet. 2/12/2005, Vol. 365 Issue 9459, p573-578. 6p.

Zobrazit plný text záznamu